Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

by | Jun 29, 2026 | General

U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining more than 1% on Monday.

Shares of Biohaven Ltd (NASDAQ:BHVN) fell sharply in pre-market trading. Biohaven announced enrollment of first patient in its pivotal Phase 3 trial of BHV-1300 for Graves’ disease.

B of A Securities analyst Jason Gerberry downgraded Biohaven from Neutral to Underperform and lowered the price target from $12 to $11.

Biohaven shares tumbled 5.2% to $15.00 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

  • Larimar Therapeutics Inc (NASDAQ:LRMR) shares tumbled 22.1% to $2.85 in pre-market trading as the company submitted first module of rolling BLA submission to the FDA for accelerated approval of Nomlabofusp.
  • Omeros Corp (NASDAQ:OMER) shares dipped 15.6% to $9.05 in pre-market trading.
  • Sadot Group Inc (NASDAQ:SDOT) fell 15.6% to $18.08 in pre-market trading after jumping 247% on Friday.
  • Freecast Inc (NASDAQ:CAST) declined 13.8% to $6.60 in pre-market trading after falling 12% on Friday.
  • TopBuild Corp (NYSE:BLD) fell 7.3% to $395.00 in pre-market trading. Toast Inc. (NYSE:TOST) will replace TopBuild in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, July 1.
  • Pershing Square Inc (NYSE:PS) declined 6.2% to $29.59 in pre-market trading after gaining 6% on Friday.
  • ChipMOS Technologies Inc – ADR (NASDAQ:IMOS) fell 5.5% to $57.22 in pre-market trading.
  • Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) declined 5% to $75.00 in pre-market trading.
  • ProKidney Corp (NASDAQ:PROK) declined 4.4% to $1.75 in pre-market trading after gaining around 8% on Friday.
  • Gerdau SA ADR (NYSE:GGB) fell 3.6% to $4.00 in pre-market trading.
  • DiaMedica Therapeutics Inc (NASDAQ:DMAC) dipped 3.4% to $6.33 in pre-market trading.
  • Evommune Inc (NYSE:EVMN) slipped 3.3% to $24.34 in pre-market trading.
  • Goodyear Tire & Rubber Co (NASDAQ:GT) fell 3% to $6.64 in pre-market trading. Christina L. Zamarro, executive vice president and chief financial officer, notified the company that she will step down from her current position effective June 30, and leave the Company on July 10.

Photo via Shutterstock